Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ligand Binding Sites02:40

Ligand Binding Sites

12.8K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.8K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

699
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
699
Ligand Binding and Linkage00:49

Ligand Binding and Linkage

4.8K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked.  In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.8K
The Equilibrium Binding Constant and Binding Strength02:18

The Equilibrium Binding Constant and Binding Strength

12.9K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
12.9K
Conserved Binding Sites01:49

Conserved Binding Sites

4.2K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
4.2K
Protein-protein Interfaces02:04

Protein-protein Interfaces

12.5K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Biomechanical evaluation of a fully cortical-threaded screw for modified cortical bone trajectory fixation: Combined experimental and finite element study.

Proceedings of the Institution of Mechanical Engineers. Part H, Journal of engineering in medicine·2026
Same author

Comparison of the efficacy of posterior lumbar interbody fusion and transforaminal lumbar interbody fusion in the treatment of double-level lumbar spondylolisthesis combined with spinal stenosis: a retrospective comparative study.

BMC surgery·2026
Same author

Impact of Alkyl Side Chain Length on Morphological Properties and Magnetic Field Response Characteristics of Naphthalenediimide-Based Conjugated Polymer.

Polymers·2026
Same author

Hyaluronic Acid Improves Stability in Ovalbumin-Tea Polyphenol Pickering Particle-Stabilized Gel-like HIPEs via Interfacial Reinforcement.

Gels (Basel, Switzerland)·2026
Same author

Large Language Models and Their Applications in Mental Health: Scoping Review.

JMIR mental health·2026
Same author

REBACIN<sup>®</sup> can remove high-risk Human Papillomavirus (HPV) persistent infection efficiently as an effective non-invasive treatment: a multicenter prospective study.

World journal of surgical oncology·2026
Same journal

conMItion: an R package adjusting confounding factors for associations in multi-omics.

Bioinformatics (Oxford, England)·2026
Same journal

SpaMFG: a Spatial Multi-omics Integration Method based on Feature Grouping.

Bioinformatics (Oxford, England)·2026
Same journal

CSCN: Inference of Cell-Specific Causal Networks Using Single-Cell RNA-Seq Data.

Bioinformatics (Oxford, England)·2026
Same journal

Sparse CCA-Based Mediation Analysis with High-Dimensional Exposures and Mediators.

Bioinformatics (Oxford, England)·2026
Same journal

Enhancing Cross-Context Generalization in Drug Perturbation Prediction with a Multimodal Conditional Diffusion Framework.

Bioinformatics (Oxford, England)·2026
Same journal

Primer Design through Submodular Function Estimation.

Bioinformatics (Oxford, England)·2026
See all related articles

Related Experiment Video

Updated: Jun 23, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

925

OLB-AC: toward optimizing ligand bioactivities through deep graph learning and activity cliffs.

Yueming Yin1,2, Haifeng Hu1, Jitao Yang1

  • 1School of Telecommunications and Information Engineering, Nanjing University of Posts and Telecommunications, Nanjing 210003, China.

Bioinformatics (Oxford, England)
|June 18, 2024
PubMed
Summary
This summary is machine-generated.

This study introduces a novel deep graph learning method to optimize drug molecules near activity cliffs, improving bioactivity prediction and generating novel, effective compounds. The approach enhances drug discovery by identifying optimized ligands with improved properties.

More Related Videos

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.5K
Author Spotlight: Exploring Cellular Processes by Modeling Ligands in Cryo-EM Maps
09:30

Author Spotlight: Exploring Cellular Processes by Modeling Ligands in Cryo-EM Maps

Published on: July 19, 2024

1.3K

Related Experiment Videos

Last Updated: Jun 23, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

925
Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.5K
Author Spotlight: Exploring Cellular Processes by Modeling Ligands in Cryo-EM Maps
09:30

Author Spotlight: Exploring Cellular Processes by Modeling Ligands in Cryo-EM Maps

Published on: July 19, 2024

1.3K

Area of Science:

  • Computational chemistry and cheminformatics
  • Drug discovery and development
  • Machine learning and artificial intelligence in chemistry

Background:

  • Deep graph learning (DGL) is crucial for ligand-based virtual screening.
  • Activity cliffs (ACs) pose a challenge, as small molecular changes drastically alter bioactivity.
  • Existing DGL models improve prediction near ACs, but optimization opportunities remain underexplored.

Purpose of the Study:

  • To develop a novel deep graph learning approach for simultaneous prediction and optimization of ligand bioactivities near activity cliffs.
  • To introduce a method that directly optimizes ligand molecules, providing a reference for enhancing bioactivity.
  • To explore the potential of activity cliffs for optimizing ligand bioactivity in drug discovery.

Main Methods:

  • Proposed a novel approach named OLB-AC (Optimizing Ligand Bioactivities near Activity Cliffs) utilizing deep graph learning.
  • Developed an attentive graph reconstruction neural network to reconstruct and optimize ligands.
  • Employed adversarial representations derived from bioactivity prediction gradients for ligand optimization.

Main Results:

  • OLB-AC successfully optimized 667 molecules, identifying 49 known highly active/inhibitor/non-toxic ligands beyond the training datasets.
  • Generated 27 novel molecular pairs with transformations not present in the training sets.
  • Achieved state-of-the-art performance in bioactivity prediction, showing the best Pearson correlation coefficient (r2) on 27/33 datasets, with 7.2%-22.9% improvement.

Conclusions:

  • The OLB-AC method effectively optimizes ligand bioactivities near activity cliffs, demonstrating significant potential in drug discovery.
  • The approach generates novel molecular transformations and improves bioactivity prediction accuracy.
  • Code and datasets are publicly available, facilitating further research in DGL for drug optimization.